Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSKOTX1 is an inhibitor of aldehyde dehydrogenase 1A3 (ALDH1A3; IC50 = 5.14 nM).1 It potentiates glucose-induced insulin secretion from pancreatic islets isolated from patients with type 2 diabetes when used at a concentration of 10 µM. KOTX1 (40 mg/kg per day) decreases plasma insulin levels and reduces blood glucose levels in an intraperitoneal glucose tolerance test (IPGTT) in diabetic db/db male mice. It decreases blood glucose levels and increases plasma insulin levels in a mouse model of obesity induced by a high-fat diet when administered in the diet at 270 ppm.
WARNING This product is not for human or veterinary use.
1. Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-